PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

BRISTOL-MYERS SQUIBB COMPANY

DC · US

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$16,160,000

Connections

15

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$30.5M
MMMMedicare/Medicaid
$30.4M
TAXTaxation/Internal Revenue Code
$29.0M
CPTCopyright/Patent/Trademark
$26.9M
TRDTrade
$22.9M
PHAPharmacy
$14.5M
BUDBudget/Appropriations
$2.3M
MANManufacturing
$600K

Lobbying Firms Retained

BRISTOL-MYERS SQUIBB COMPANY$28.7M
TODD STRATEGY GROUP$930K
WILLIAMS AND JENSEN, PLLC$290K
CROSSROADS STRATEGIES, LLC$280K
AVENUE SOLUTIONS$120K
MARSHALL & POPP, LLC$100K
W STRATEGIES, LLC$80K
MILLER STRATEGIES, LLC$30K
SQUIRE PATTON BOGGS$10K
ADVANCED POLICY CONSULTING, LLC$0

Bills Referenced in Lobbying Filings

march-inPBM

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Employed byCROSSROADS STRATEGIES, LLCHired CROSSROADS STRATEGIES, LLC to lobby on NIH March-In RightsSource
Employed byTIBER CREEK GROUPHired TIBER CREEK GROUP to lobby on PharmaceuticalsSource
commented_onCenters for Medicare & Medicaid ServicesPublic comment on CMS-2025-1889: Global Benchmark for Efficient Drug Pricing ModelSource
Lobbied forPharmacy Benefit Manager Reform ActLDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,410,000Source
Lobbied forAction to Delay Effective Date Consistent With Congressionally Enacted MoratoriumLobbied on pbm — matched LDA filing topic to Federal Register rule.Source
Lobbied forImproving Transparency Into Pharmacy Benefit Manager Fee Disclosure; Extension of Comment PeriodLobbied on pbm — matched LDA filing topic to Federal Register rule.Source
Lobbied forRights to Federally Funded Inventions and Licensing of Government Owned InventionsLobbied on march-in — matched LDA filing topic to Federal Register rule.Source
Employed bySQUIRE PATTON BOGGSHired SQUIRE PATTON BOGGS to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byTODD STRATEGY GROUPHired TODD STRATEGY GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byWILLIAMS AND JENSEN, PLLCHired WILLIAMS AND JENSEN, PLLC to lobby (3rd Quarter (July 1 - Sep 30) 2025)Source
Employed byMILLER STRATEGIES, LLCHired MILLER STRATEGIES, LLC to lobby (3rd Quarter (July 1 - Sep 30) 2025)Source
Employed byW STRATEGIES, LLCHired W STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2026)Source
Employed byMARSHALL & POPP, LLCHired MARSHALL & POPP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2026)Source
Employed byAVENUE SOLUTIONSHired AVENUE SOLUTIONS to lobby (1st Quarter (Jan 1 - Mar 31) 2026)Source
Employed byADVANCED POLICY CONSULTING, LLCHired ADVANCED POLICY CONSULTING, LLC to lobby (3rd Quarter (July 1 - Sep 30) 2026)Source